Support scientifique
Bibliographie

Bibliographie

Des articles et posters publiés sur la plasmaphérèse et les techniques développées sur le moniteur Plasauto Σ.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Laura Connelly-Smith, Caroline R Alquist, Nicole A Aqui, Jan C Hofmann, Reinhard Klingel, Oluwatoyosi A Onwuemene, Christopher J Patriquin, Huy P Pham, Amber P Sanchez, Jennifer Schneiderman, Volker Witt, Nicole D Zantek, Nancy M Dunbar
J Clin Apher. 2023 Apr;38(2):77-278.
doi: 10.1002/jca.22043.

Rheopheresis Performed in Hemodialysis Patients Targets Endothelium and Has an Acute Anti- Inflammatory Effect
Justine Solignac, Romaric Lacroix, Laurent Arnaud, Evelyne Abdili, Dammar Bouchouareb, Stéphane
Burtey, Philippe Brunet, Françoise Dignat-George, Thomas Robert
J Clin Med. 2022 Dec 23;12(1):105.
doi: 10.3390/jcm12010105.

La rhéophérèse : expérience d’un centre d’hémodialyse
E. Ismail, S. Aghamir, B. Jonon, R. Bourouma
Néphrologie & Thérapeutique Vol 18 – N° 5 P. 434 – septembre 2022
doi : 10.1016/j.nephro.2022.07.094

Évolution favorable de lésions d’AOMI avec troubles trophiques traitées par rhéophérèse et thiosulfate chez l’hémodialysé chronique
S.Azria, S. El Badaoui, P.A. Michel, M.A. Lammouchi, H. Fessi
Néphrologie & Thérapeutique Vol 17, Issue 5, September 2022, Pages 373-374, PO-D58
https://doi.org/10.1016/j.nephro.2021.07.061

Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series
Justine Solignac, Stanislas Bataille, Maxime Touzot, Flora Bruner, Dammar Bouchouareb, Philippe Brunet, Christophe Ridel, Thomas Robert
J Clin Apher. 2021 Dec 7.
doi: 10.1002/jca.21955.

Données cliniques et biologiques d’une cohorte d’hémodialysés traités par rhéophérèse dans l’ischémie critique chronique de membres
J. Solignac, P. Brunet, F. Brunner, S. Bataille, T. Robert
Néphrologie & Thérapeutique 2019 – Vol 15 N° 5 septembre 2019 Page 327
doi.org/10.1016/j.nephro.2019.07.157

Acute and chronic effects of therapeutic apheresis.
Ramunni A, Petrarulo F, Grasso C, Papagni S, Brescia P.
Atheroscler Suppl. 2013 Jan;14(1):83-7
doi: 10.1016/j.atherosclerosissup.2012.10.018

Rheopheresis in vascular diseases.
Blaha M, Rencova E, Blaha V, Maly R, Blazek M, Andrys C, Drsata J, Mistrik E, Fatorova I, Dusova J.
Int J Artif Organs. 2008 May;31(5):456-7.
PMID: 18609520

Rheopheresis in vascular diseases.
Ferrannini M, Vischini G, Staffolani E, Scaccia F, Miani N, Parravano MC, Louis MM, Splendiani G, Di Daniele N.
Int J Artif Organs. 2007 Oct;30(10):923-9.
doi: 10.1177/039139880703001010.

Rheopheresis in patients with critical limb ischemia–results of an open label prospective pilot trial.
Klingel R, Erdtracht B, Gauss V, Piazolo A, Mausfeld-Lafdhiya P, Diehm C.
Ther Apher Dial. 2005 Dec;9(6):473-81.
doi: 10.1111/j.1744-9987.2005.00276.x

Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.
Klingel R, Mumme C, Fassbender T, Himmelsbach F, Altes U, Lotz J, Pohlmann T, Beyer J, Küstner E.
Ther Apher Dial. 2003 Aug;7(4):444-55.
doi: 10.1046/j.1526-0968.2003.00082.x

Calciphylaxie non urémique iatrogène : une nouvelle observation
Soumaya Hamich, Julien Rakotoson, Martin Mazereeuw, Hugo Tristani, Olivier Lavelle, Michèle Sanchez, Brigitte Lagrange
Nephrol Ther. 2020 Nov 8;S1769-7255(20)30359-X.
doi: 10.1016/j.nephro.2020.09.002.

Rheopheresis: A new therapeutic approach in severe calciphylaxis.
Robert T, Lionet A, Bataille S, Seret G.
Nephrology (Carlton). 2019 Oct 1.
doi: 10.1111/nep.13666.

Hemodialysis coupled with rheopheresis in calciphylaxis: A winning combination.
Naciri Bennani H, Jouve T, Boudjemaa S, Gil H, Rostaing L.
J Clin Apher. 2019 Oct;34(5):631-633.
doi: 10.1002/jca.21736.

Traitement de la calciphylaxie par rhéophérèse : série de cas
G.Seret, S.Bataille, A.Lionet, T.Robert.
Néphrologie & Thérapeutique Vol 14, Issue 5, Sept 2018, P 313. Et poster SFNDT 2018

Calciphylaxis.
Maanaoui M, Provôt F, Lionet A.
N Engl J Med. 2018 Jul 26;379(4):398.
doi: 10.1056/NEJMc1807324.

Rheopheresis for Adjuvant Treatment in Resistant Calciphylaxis.
Bouderlique E, Provot F, Lionet A.
Ther Apher Dial. 2018 Feb 11.
doi: 10.1111/1744-9987.12666.

Expérience de la rhéophérèse en traitement adjuvant de la calciphylaxie
É. Bouderlique, A. Lionet, F. Provot, T. Dekeyser, J. Zaworski, C. Lessore De Sainte Foy, C. Noel.
Néphrologie & Thérapeutique – Vol. 13 – N° 5 – p. 318 – septembre 2017
Et poster SFNDT 2017

Rheopheresis in the treatment of age-related macular degeneration.
Langrová H, Rencová E, Bláha M, Studnička J, Stě A, Breznayová J, Burova M, Jedličková Š, Dvořáková H, Bláha V, Lánská M.
Cesk Slov Oftalmol. 2022 Winter;79(1):8-24.
doi: 10.31348/2023/2.

Rheopheresis and its Use in the Treatment of Diseases with Impaired Microcirculation. A Review
Paříková A.
Cesk Slov Oftalmol. 2022 Winter;79(1):3-5.
doi: 10.31348/2023/1.

Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis.
Rencová E, Bláha M, Studnička J, Bláha V, Lánská M, Renc O, Stepanov A, Kratochvílová V, Langrová H.
J Ophthalmol. 2015;2015:359747.
doi: 10.1155/2015/359747.

Changes of the complement system and rheological indicators after therapy with rheohemapheresis.
Blaha M, Andrys C, Langrova H, Studnicka J, Drsata J, Lanska M, Blaha V, Zak P.
Atheroscler Suppl. 2015 May;18:140-5.
doi: 10.1016/j.atherosclerosissup.2015.02.009.

Reduction in the drusenoid retinal pigment epithelium detachment area in the dry form of age-related macular degeneration 2.5 years after rheohemapheresis.
Rencová E, Bláha M, Studnička J, Bláha V, Brožík J, Pazderová M, Rozsíval P, Langrová H.
Acta Ophthalmol. 2013 Aug;91(5):e406-8.
doi: 10.1111/j.1755-3768.2012.02503.x.

Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form.
Rencová E, Bláha M, Studnička J, Blažek M, Bláha V, Dusová J, Malý J, Kyprianou G, Vašátko T, Langrová H.
Acta Ophthalmol. 2011 Aug;89(5):463-71.
doi: 10.1111/j.1755-3768.2009.01710.x.

RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration.
Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B.
Ther Apher Dial. 2010 Jun;14(3):276-86.
doi: 10.1111/j.1744-9987.2010.00807.x.

Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART.
Koss MJ, Kurz P, Tsobanelis T, Lehmacher W, Fassbender C, Klingel R, Koch FH.
Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1297-306.
doi: 10.1007/s00417-009-1113-7.

Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results.
Pulido JS, Winters JL, Boyer D.
Trans Am Ophthalmol Soc. 2006;104:221-31.
PMID: 17471343

Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.
Pulido JS; Multicenter Investigation of Rheopheresis for AMD (MIRA-1) Study Group.
Trans Am Ophthalmol Soc. 2002;100:85-106; discussion 106-7.
PMID: 12545682

Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial.
Brunner R, Widder RA, Walter P, Lüke C, Godehardt E, Bartz-Schmidt KU, Heimann K, Borberg H.
Retina. 2000;20(5):483-91.
doi: 10.1097/00006982-200009000-00009.

Rheopheresis: A narrative review.
George Kosmadakis.
Int J Artif Organs. 2022 May;45(5):445-454.
doi: 10.1177/03913988221086597.

Success of rheopheresis to treat digital hypoperfusion ischemic syndrome.
A I Keita, A B Bah, M C Balde, L Spataru, A Cadene, L Rostaing.
Ther Apher Dial. 2021 Jun;25(3):362-364.
doi: 10.1111/1744-9987.13563.

Rheopheresis for Digital Ulcers and Raynaud’s Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments.
Peter Korsten, Gerhard A. Müller, Jan-Gerd Rademacher, Michael Zeisberg, and Björn Tampe.
Front Med (Lausanne). 2019; 6: 208.
doi: 10.3389/fmed.2019.00208.

La rhéophérèse : option thérapeutique dans la maladie des emboles de cholestérol chez le patient dialysé.
C.Stein, M.Laforet, G.Cavaille, P.Brunet & T.Robert.
Néphrologie & Thérapeutique 14 (2018) 292.

Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.
Balletshofer BM, Stock J, Rittig K, Lehn-Stefan A, Braun N, Burkart F, Plontke S, Klingel R, Häring HU.
Ther Apher Dial. 2005 Oct;9(5):385-90.
doi: 10.1111/j.1744-9987.2005.00316.x.

Rheopheresis for idopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial.
Mösges R, Köberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W; RHEO-ISHL Study Groupe.
Eur Arch Otorhinolaryngol. 2009 Jul;266(7):943-53.
doi: 10.1007/s00405-008-0823-5.

Rheopheresis for recurrent sudden hearing loss: therapeutic options for patients refractory to infusion therapy.
Uygun-Kiehne S, Straube R, Heibges A, Klingel R, Davids H.
HNO. 2010 May;58(5):445-51.
doi: 10.1007/s00106-009-2004-2. 

Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.
Leebmann J, Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Maerz W, Lehmacher W, Heibges A, Klingel R; Pro(a)LiFe Study Group.
Circulation. 2013 Dec 17 ;128(24):2567-76.
doi: 10.1161/CIRCULATIONAHA.113.002432.

Lipidfiltration – safe and effective methodology to perform lipid-apheresis.
Klingel R, Mausfeld P, Fassbender C, Gohlen B.
Transfusion and Apheresis Science, 2004, 30, 245-254
doi: 10.1016/j.transci.2004.01.008.

From Membrane Differential Filtration to Lipidfiltration: Technological Progress in Low-density Lipoprotein Apheresis.
Klingel R, Fassbender T, Fassbender C, Göhlen B.
Ther Apher Dial. 2003 Jun;7(3):350-8.
doi: 10.1046/j.1526-0968.2003.00062.x.

Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience.
Jha PK, Tiwari AK, Bansal SB, Sethi SK, Ahlawat R, Kher V.
Transfusion. 2016 Apr;56(4):956-61.
doi: 10.1111/trf.13427.

Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S, Hwang E, Park S, Park U, Kim H, Cho W.
Exp Clin Transplant. 2014 Oct;12(5):401-4.
PMID: 25299367

Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption.
Thalgahagoda S, Webb NJ, Roberts D, Birch A. Milford DV, Tavakoli A, Shenoy M.
Pediatr Transplant. 2014 May;18(3):E74-6
doi: 10.1111/petr.12227.

Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
Higgins R, Lowe D, Hathaway M, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Chen K, Krishnan N, Hamer R, Zehnder D, Briggs D.
Ther Apher Dial. 2010 Aug 1;14(4):392-9.
doi: 10.1111/j.1744-9987.2010.00821.x.

Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.
Uchida J, Machida Y, Iwai T, Naganuma T, Kitamoto K, Iguchi T, Maeda S, Kamada Y, Kuwabara N, Kim T, Nakatani T.
Transplant Proc. 2010 Dec;42(10):3998-4002.
doi: 10.1016/j.transproceed.2010.09.043.

Results of kidney transplantation from ABO-incompatible Living Donors in a single institution.
T. Kenmochi, K. Saigo, M. Maruyama, N. Akutsu, C. Iwashita, K. Otsuki, T. Ito, A. Suzuki and M. Miyazaki
Transplant Proc. 2008 Sep;40(7):2289-91.
doi: 10.1016/j.transproceed.2008.06.039.

Double filtration plasmapheresis.
K Tanabe
Transplantation 2007;84:S30-32.
doi: 10.1097/01.tp.0000296103.34735.b8.

Therapeutic plasma exchange and Double filtration plasmapheresis in severe neuroimmune disorders
Corina Roman-Filip , Maria-Gabriela Catană , Alina Bereanu, Ana Lăzăroae, Felicia Gligor, Mihai Sava.
Acta Clin Croat. 2019 Dec;58(4):621-626.
doi: 10.20471/acc.2019.58.04.08.

Treatment of refractory myasthenia gravis by double-filtration plasmapheresis and rituximab: A case series of nine patients and literature review
Hamza N Bennani, Emmeline Lagrange, Johan Noble, Paolo Malvezzi, Lionel Motte, Eloi Chevallier, Lionel Rostaing, Thomas Jouve
J Clin Apher. 2020 Dec 21.
doi: 10.1002/jca.21868.

Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action
Lei Zhang, Junfeng Liu, Hongna Wang, Chongbo Zhao, Jiahong Lu, Jun Xue, Yong Gu, Chuanming Hao, Shanyan Lin, Chuanzheng Lv
J Clin Neurosci. 2014 Sep;21(9):1570-4.
doi: 10.1016/j.jocn.2013.11.046.

Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days.
Satoko Miyamoto, Atsushi Ohkubo, Hiroshi Seshima, Hiroko Yamamoto, Ayako Itagaki, Takuma Maeda, Naoki Kurashima, Takayasu Mori, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida, Tomokazu Okado.
Ther Apher Dial. 2018 Jun;22(3):255-260.
doi: 10.1111/1744-9987.12692.

Selective plasma exchange.
Atsushi Ohkubo, Tomokazu Okado.
Transfus Apher Sci. 2017 Oct;56(5):657-660.
doi: 10.1016/j.transci.2017.08.010.

Fibrinogen Reduction During Selective Plasma Exchange due to Membrane Fouling. Atsushi Ohkubo, Tomokazu Okado, Satoko Miyamoto, Yurie Hashimoto, Shigeto Komori, Motoki Yamamoto, Takuma Maeda, Ayako Itagaki, Hiroko Yamamoto, Hiroshi Seshima, Naoki Kurashima, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Shinichi Uchida, Tatemitsu Rai.
Ther Apher Dial. 2017 Jun;21(3):232-237.
doi: 10.1111/1744-9987.12564.

Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.
Mayuko Kawabe, Izumi Yamamoto, Ai Katsuma, Naomi Hayashi, Yo Komatsuzaki, Yasuyuki Nakada, Akihiro Shimizu, Yudo Tanno, Ichiro Ohkido, Nobuo Tsuboi, Kazuhito Suzuki , Takaki Shimada, Yoji Ogasawara, Katsuki Sugiyama, Keisuke Aiba, Takashi Yokoo.
CEN Case Rep. 2016 Nov;5(2):232-237.
doi: 10.1007/s13730-016-0231-4.

Removal Dynamics of Immunoglobulin and Fibrinogen by Conventional Plasma Exchange, Selective Plasma Exchange, and a Combination of the Two.
Satoko Miyamoto, Atsushi Ohkubo, Hiroshi Seshima, Takuma Maeda, Ayako Itagaki , Naoki Kurashima, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida, Tomokazu Okado.
Ther Apher Dial. 2016 Aug;20(4):342-7.
doi: 10.1111/1744-9987.12465.

Renal Improvement With Molecular-Selective Plasma Exchange in a Patient With Bence-Jones Type Multiple Myeloma.
Manabu Kanda, Satoru Sanada, Hiromi Kowata, Shinichi Mizuno, Shu Yamakage, Mitsuhito Sato, Toshinobu Sato, Yoshio Taguma.
Ther Apher Dial. 2016 Aug;20(4):420-2.
doi: 10.1111/1744-9987.12472.

Solute Removal Capacity of High Cut-Off Membrane Plasma Separators.
Atsushi Ohkubo, Naoki Kurashima, Ayako Nakamura, Satoko Miyamoto, Soichiro Iimori, Tatemitsu Rai.
Ther Apher Dial. 2013 Oct;17(5):484-9.
doi: 10.1111/1744-9987.12114.

EVACURE™*—Membrane Plasma Separator with Unique Permeability Properties.
Kumiko Taniguchi, Tadashi Miyahara Medical.
Science Digest Vol. 28 (6), 2002

Clinical Evidence of Immunoadsorption Column for Desensitization in ABO-incompatible Renal Transplantation (ABOi-RTx) Patients: A Case Series
Vikram Kalra, Salil Jain, Yogeshman Anand, Ambar Khaira and Umesh Gupta
Journal of Clinical & Experimental Nephrology 2023 DOI 10.36648/2472-5056.8.4.205

Success in the ABO-Incompatible Kidney Transplantation: A Case Report.
Rana DS, Bhalla AK, Gupta A, Malik M, Gupta A. Enhancing
Cureus. 2024 Jun 14;16(6):e62350.
doi: 10.7759/cureus.62350.

Plasorba

A comparison among three different apheretic techniques for treatment of hyperbilirubinemia. Viggiano D, de Pascale E, Marinelli G, Pluvio C.
J Artif Organs. 2018 Mar;21(1):110-116.
doi: 10.1007/s10047-017-0986-1.

The Effectiveness of Bilirubin Column on Severe Hyperbilirubinemia in a Patient with Cardiac Cirrhosis.
Coşkun R, Uslup S, Gündoğan K, Pala Ç, İsmail Hakkı Akbudak, Sungur M, Güven M.
Erciyes Med J 2014 36(2): 82-4
DOI:10.5152/etd.2014.7563

Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters.
Krawczyk M, Grünhage F, Langhirt M, Bohle RM, Lammert F.
Ann Hepatol. 2012 Sep-Oct;11(5):710-4.
PMID: 22947535

Safety and efficacy of extracorporeal bilirubin-adsorption in patients with acute renal and liver failure.
Susanne Amann, Kerstin Humme, Uwe Kuhlmann.
NDT 2012

Selective bilirubin removal by plasma treatment with Plasorba BR-350 for early cholestatic graft dysfunction.
Adani GL, Lorenzin D, Currò G, Sainz-Barriga M, Comuzzi C, Bresadola V, Avellini C, Baccarani U.
Transplant Proc. 2007 Jul-Aug;39(6):1904-6.
doi: 10.1016/j.transproceed.2007.05.010.

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis.
Pusl T, Denk GU, Parhofer KG, Beuers U.
J Hepatol. 2006 Dec;45(6):887-91.
doi: 10.1016/j.jhep.2006.08.008.

Bilirubin-adsorption in 23 critically ill patients with liver failure.
Senf R, Klingel R, Kurz S, Tullius S, Sauer I, Frei U, Schindler R.
Int J Artif Organs. 2004 Aug;27(8):717-22.
doi: 10.1177/039139880402700810.

Removal of protein-bound and unbound unconjugated bilirubin by perfusion of plasma through an anion-exchange resin in a case of Crigler-Najjar syndrome type I.
Ihara H, Shino Y, Hashizume N, Shimizu N, Aoki T, Yoshida M.
Ann Clin Biochem. 2003 Sep;40(Pt 5):528-33.
doi: 10.1258/000456303322326443.

Plasma separation and bilirubin adsorption for excessive hyperbilirubinemia before and after liver transplantation.
E Mancini, S Faenza, E Mambelli et A Santoro.
Critical Care 2002, 6(Suppl 1):P188.

Coagulopathy after bilirubin adsorption in a living-related partial liver transplant recipient.
Ishida H, Sato S, Sannomiya A, Tsuji K, Yoshimura N, Nakamura M, Koyama I, Kitajima K, Tojimbara T, Nakajima I, Fuchinoue S, Takasaki K, Agishi T.
Transplant Proc. 2000 Nov;32(7):2241-2.
doi: 10.1016/s0041-1345(00)01651-1.

Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.
Mertens PR, Schönfelder T, Handt S, Kierdorf H, Marschall H, Busch N, Heintz B, Sieberth H.
Blood Purif. 1998;16(6):341-8.
doi: 10.1159/000014354.

Plasma separation and bilirubin adsorption after complicated liver transplantation: a therapeutic approach to excessive hyperbilirubinemia.
Ott R, Rupprecht H, Born G, Müller V, Reck T, Hohenberger W, Köckerling F.
Transplantation. 1998 Feb 15;65(3):434-7.
doi: 10.1097/00007890-199802150-00025.

Bilirubin adsorbent column for plasma perfusion.
Takenaka Y.
Ther Apher. 1998 May;2(2):129-33.
doi: 10.1111/j.1744-9987.1998.tb00090.x.

Immusorba

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses.
Steffen Pfeuffer, Leoni Rolfes, Timo Wirth, Falk Steffen, Marc Pawlitzki, Andreas Schulte-Mecklenbeck, Catharina C Gross, Marcus Brand, Stefan Bittner, Tobias Ruck, Luisa Klotz, Heinz Wiendl, Sven G Meuth.
J Neuroinflammation. 2022 Sep 7;19(1):220.
doi: 10.1186/s12974-022-02583-y.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.
Ingo Kleiter et al; NEMOS (Neuromyelitis Optica Study Group).
Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504.
doi: 10.1212/NXI.0000000000000504.

A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.
Ina Lieker, Torsten Slowinski, Lutz Harms, Katrin Hahn, Juliane Klehmet.
J Clin Apher. 2017 Dec;32(6):486-493.
doi: 10.1002/jca.21546.

Immunoadsorption using Immusorba TR and PH.
Ryuichiro Hirano, Noriko Hirata.
Transfus Apher Sci. 2017 Oct;56(5):661-665.
doi: 10.1016/j.transci.2017.08.011.

Immunoadsorption for autoimmune encephalitis.
Fassbender C, Klingel R, Köhler W.
Atheroscler Suppl. 2017 Nov;30:257-263.
doi: 10.1016/j.atherosclerosissup.2017.05.041.

Escalation Therapy of Steroid Refractory Multiple Sclerosis Relapse with Tryptophan Immunoadsorption – Observational Multicenter Study with 147 Patients.
Sebastian Schimrigk, Jürgen Faiss, Wolfgang Köhler, Albrecht Günther, Lutz Harms, Andrea Kraft, Sven Ehrlich, Axel Eberl, Cordula Fassbender, Reinhard Klingel, Jan Galle, Arne Riedlinger, Frank Hoffmann.
Eur Neurol. 2016;75(5-6):300.
doi: 10.1159/000447059.

Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
Heigl F, Hettich R, Arendt R, Durner J, Koehler J, Mauch E.
Atheroscler Suppl. 2013 Jan;14(1):167-73.
doi: 10.1016/j.atherosclerosissup.2012.10.025.

A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Wolfgang Köhler, Christoph Bucka, Reinhard Klingel.
Clin Apher. 2011 Dec;26(6):347-55.
doi: 10.1002/jca.20317.

Page mise à jour: 13 janvier 2025

Support scientifique